< Terug naar vorige pagina
Onderzoeker
Mustafa Varcin
- Trefwoorden:Farmacie
Affiliaties
- Experimentele Farmacologie (Onderzoeksgroep)
Lid
Vanaf2 feb 2017 → 18 mrt 2019 - Farmaceutische Chemie, Analyse van Geneesmiddelen en Geneesmiddelenkennis (Departement)
Lid
Vanaf1 okt 2008 → 30 sep 2012
Projecten
1 - 1 of 1
- Neuro-TARGET : integrated platform for target identification, validation and drug discovery with applications for neurodegenerative diseases.Vanaf1 jan 2009 → 31 dec 2012Financiering: SBO (Strategisch Basisonderzoek)
Publicaties
1 - 8 van 8
- Involvement of CRH Receptors in the Neuroprotective Action of R-Apomorphine in the Striatal 6-OHDA Rat Model(2013)
Auteurs: Mustafa Varcin, Eduard Bentea, Steven Roosens, Sophie Sarre
Pagina's: 299-318 - Oxidative stress in genetic mouse models of Parkinson’s disease(2012)
Auteurs: Mustafa Varcin, Eduard Bentea, Sophie Sarre
- Acute versus long-term effects of 6-hydroxydopamine on oxidative stress and dopamine depletion in the striatum of mice(2011)
Auteurs: Mustafa Varcin, Eduard Bentea, Chris Van Den Haute, Veerle Baekelandt, Sophie Sarre
Pagina's: 128-136 - The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death(2011)
Auteurs: Mustafa Varcin, Sophie Sarre
Pagina's: 1141-1148 - Glutamate – dopamine interactions in the subthalamic nucleus. (Oral)(2010)Series: Monitoring Molecules in Neuroscience
Auteurs: Sophie Sarre, Ben Ampe, Anissa El Arfani, Mustafa Varcin
Pagina's: 75-77Aantal pagina's: 3 - Susceptibility of PINK-1 deficient mice to 6-OHDA induced oxidative stress determined
with in vivo salicylate trapping(2010)Series: Monitoring Molecules in Neuroscience
Auteurs: Mustafa Varcin, Bavo Heeman, Chris Van Den Haute, Veerle Baekelandt, Sophie Sarre
Pagina's: 476-478Aantal pagina's: 3 - In vivo study of the neuroprotective effects of candesartan against 6-hydroxydopamine induced neurotoxicity(2008)
Auteurs: Mustafa Varcin, Sophie Sarre
Pagina's: 78 - In vivo neurochemical and neuroprotective effects of candesartan in the 6-hydroxydopamine rat model of Parkinson's disease(2008)
Auteurs: Mustafa Varcin, Sophie Sarre
Pagina's: 3